“…This practice seems unchanged despite knowledge about adverse outcome in this population. The current ACC/AHA guidelines for patients with stable CAD echoes the ACC/AHA recommendations for patients with unstable angina/non–ST‐segment–elevation MI for subgroups of patients with no obstructive CAD, which was defined as CSX 22, 78. While there have been studies evaluating therapy in patients with CSX,79, 80, 81, 82 these studies are limited in their characterization of coronary vasomotor function.…”